Moreover, leptin and adiponectin showed protective effect on the nonalcoholic fatty liver disease, respectively (Machado et al., 2012 ▶; Matsunami et al., 2010 ▶). Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.